Alectinib
Back to searchMolecule Structure
Scientific Name
Alectinib
Description of the Drug
Alectinib is a kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11363
http://www.drugbank.ca/drugs/DB11363
Brand Name(s)
Alecensa
Company Owner(s)
Hoffmann-La Roche Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| ALK tyrosine kinase receptor | SINGLE PROTEIN | INHIBITOR | CHEMBL4247 |
| EML4-ALK | CHIMERIC PROTEIN | INHIBITOR | CHEMBL3883330 |
| Tyrosine-protein kinase receptor RET | SINGLE PROTEIN | INHIBITOR | CHEMBL2041 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL896753 | ||
| PharmGKB | PA166160050 | ||
| Human Metabolome Database | HMDB0248129 | ||
| DrugBank | DB11363 | ||
| PubChem: Thomson Pharma | 103778663 | ||
| PubChem | 49806720 | ||
| LINCS | LSM-1202 | ||
| Nikkaji | J3.001.965B | ||
| PDBe | EMH | ||
| BindingDB | 50362781 | ||
| EPA CompTox Dashboard | DTXSID50154840 | ||
| DrugCentral | 4937 | ||
| ChemicalBook | CB62534680 | ||
| Guide to Pharmacology | 7739 | ||
| rxnorm | ALECTINIB | ALECENSA | ALECTINIB HYDROCHLORIDE |
| ChEBI | 90936 | ||
| ZINC | ZINC000066166864 |
